First Manhattan’s NuVasive, Inc. NUVA Stock Holding History

First Manhattan’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-100	Closed	-$6K	–	1646
2021 Q1	$6K	Buy	100 +86	+614%	+$5.16K	﹤0.01%	1321
2020 Q4	$0	Buy	+14	New	+$689	﹤0.01%	1434

Other funds holding NUVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Manhattan's NUVA Position: Q2 2021 in Review

First Manhattan sold out of NuVasive, Inc. (NUVA) in Q2 2021, closing a stake of 100 shares — an estimated $6K sold.

First Manhattan first reported a position in NUVA in Q4 2020 and held it in 2 quarters. The position peaked at $6K in Q1 2021. 259 funds tracked by Wall St. Rank hold NUVA as of Q2 2021.

First Manhattan reported no remaining NuVasive, Inc. position as of Q2 2021 after selling out during the quarter.
First Manhattan sold 100 NuVasive, Inc. shares in Q2 2021, an estimated $6K.
First Manhattan first reported a position in NuVasive, Inc. in Q4 2020 and held it in 2 quarters.
First Manhattan's NuVasive, Inc. position peaked at $6K in Q1 2021.
259 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q2 2021.

Based on First Manhattan's 13F filing for Q2 2021, filed 16 Aug 2021.